Patients with schizophrenia have a high incidence of lifestyle diseases, such as obesity, diabetes, and dyslipidemia. Furthermore, they have a high incidence of cardiovascular disease and a short life expectancy compared with the general population. As such, these complications need to be prevented to lower the mortality risk. The first step is physical monitoring. Regular measurement of weight, waist circumference, blood pressure, fasting blood glucose, and fasting lipid level is advocated in international guidelines. There are also guidelines for diabetes mellitus in Japan, but they do not include multiple disease states such as metabolic syndrome. Thus, it is necessary to prepare and disseminate guidelines that are consistent with the current clinical situation in Japan.
 <Author's abstract>